Home Search
silo - search results
If you're not happy with the results, please do another search
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
Advances in Psychedelics can Change Investors’ Minds
Original article(s) on EXBulletin and Financial Times
The science behind this subject has become mainstream in recent years. Excellent...
That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...
Redefining how the world approaches, prevents, and heals mental health disorders.
LIVE QUOTE
CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).
Therapy Treatment Performed by Ehave's (EHVVF) Chief Medical Office Receive Rave Reviews and Offers Potential to Save Lives,
Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).
Originally in PsyTech Jan 28, 2021.
By Tessa Eskin
Big Pharma is at a crossroads....
Citius (CTXR) Announces Results of Mino-Lok Study.
"Mino-Lok has the potential to change the standard of care, which currently calls for a procedure to remove and replace the infected...
Magic Mushroom Compass Pathways (CMPS) IPO Valued at Near $1 Billion.
Shares jumped 71% to $29 in New York after an initial public offering of 7.5 million shares priced at $17 each...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April...
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
